Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Posttransplant Cyclophosphamide Promote Naïve-Subset Dominant B Cell Recovery Coordinated with Early Treg Expansion; Implication of Reduced Risk of Pathogenesis into Chronic Gvhd

Miki Iwamoto, Yusuke Meguri, MD, Takumi Kondo, MD, Hiroyuki Sugiura, MD, Shuntaro Ikegawa, MD, Yasuhisa Sando, MD, Makoto Nakamura, MD, Yoshinobu Maeda, MD PhD, Ken-Ichi Matsuoka, MD PhD

Blood (2018) 132 (Supplement 1): 4566.

https://doi.org/10.1182/blood-2018-99-120081

Published: 2018

Journal Articles

Mechanistic Analysis of Prolonged Negative Impacts of Anti-CCR4 Antibody Mogamulizumab on Regulatory T Cell Homeostasis after Allogeneic Hematopoietic Stem Cell Transplantation

Yasuhisa Sando, MD, Ken-Ichi Matsuoka, MD PhD, Yusuke Meguri, MD, Takumi Kondo, MD, Shuntaro Ikegawa, MD, Hiroyuki Sugiura, MD, Makoto Nakamura, MD, Miki Iwamoto, Takeru Asano, Takanori Yoshioka, MD, Yoshinobu Maeda, MD PhD

Blood (2018) 132 (Supplement 1): 3400.

https://doi.org/10.1182/blood-2018-99-117548

Published: 2018

Journal Articles

Post-Transplant Cyclophosphamide Ameliorates Lethal Thymic GVHD By Restoring Regulatory and Effector T Cell Homeostasis in Recipients with Prior PD-1 Blockade Therapy

Shuntaro Ikegawa, MD, Yusuke Meguri, MD, Takumi Kondo, MD, Hiroyuki Sugiura, MD, Yasuhisa Sando, MD, Makoto Nakamura, MD, Miki Iwamoto, Yoshinobu Maeda, MD PhD, Ken-Ichi Matsuoka, MD PhD

Blood (2018) 132 (Supplement 1): 479.

https://doi.org/10.1182/blood-2018-99-111142

Published: 2018

Journal Articles

Early Administration of Low-Dose IL-2 Intensify Graft-Versus-Leukemia Effect without Worsening GVHD through Sequential Enhancement of Effector T Cell and CD62L+ Regulatory T Cell Subset

Yusuke Meguri, MD, Ken-ichi Matsuoka, MDPhD, Shuntaro Ikegawa, MD, Hiroyuki Sugiura, MD, Makoto Nakamura, MD, Yasuhisa Sando, MD, Iwamoto Miki, Takanori Yoshioka, MD, Takeru Asano, MD, Yoshinobu Maeda, MDPhD

Blood (2017) 130 (Supplement 1): 3192.

https://doi.org/10.1182/blood.V130.Suppl_1.3192.3192

Published: 2017

Journal Articles

Liposomal Alpha-Galactosylceramide Ameliorates Graft-Versus-Host Disease with Remaining Intensified GVL Gained By Dose-Reduction of Posttransplant Cyclophosphamaide after Haploidentical HSCT

Makoto Nakamura, MD, Ken-ichi Matsuoka, MDPhD, Yusuke Meguri, MD, Shuntaro Ikegawa, MD, Hiroyuki Sugiura, MD, Yasuhisa Sando, MD, Miki Iwamoto, Takeru Asano, MD, Yasuyuki Ishii, PhD, Yoshinobu Maeda, MDPhD

Blood (2017) 130 (Supplement 1): 1897.

https://doi.org/10.1182/blood.V130.Suppl_1.1897.1897

Published: 2017

Journal Articles

Essential Role of Regulatory T Cells on Early B Cell Reconstitution after Haploidentical BMT with Posttransplant Cyclophosphamide

Miki Iwamoto, Ken-ichi Matsuoka, MDPhD, Yusuke Meguri, MD, Shuntaro Ikegawa, MD, Hiroyuki Sugiura, MD, Yasuhisa Sando, MD, Makoto Nakamura, MD, Takeru Asano, MD, Yoshinobu Maeda, MDPhD

Blood (2017) 130 (Supplement 1): 4447.

https://doi.org/10.1182/blood.V130.Suppl_1.4447.4447

Published: 2017

Journal Articles

Loss of the GVL Effect By Distinct Expression of Migration Markers As a Mechanism of Immune Escape in Adult T Cell Leukemia/Lymphoma (ATLL), a Malignant Counterpart of Regulatory T Cells

Yasuhisa Sando, MD, Ken-ichi Matsuoka, MDPhD, Yusuke Meguri, MD, Shuntaro Ikegawa, MD, Hiroyuki Sugiura, MD, Makoto Nakamura, MD, Iwamoto Miki, Takeru Asano, MD, Takanori Yoshioka, MD, Yoshinobu Maeda, MDPhD

Blood (2017) 130 (Supplement 1): 2760.

https://doi.org/10.1182/blood.V130.Suppl_1.2760.2760

Published: 2017

Journal Articles

Impact of Incomplete Blood Count Recovery Prior to Allogeneic Hematopoietic Stem Cell Transplantation on Engraftment and Early Infection in Patients with Acute Myeloid Leukemia

Takeru Asano, MD, Shuntaro Ikegawa, MD, Tomoko Inomata, MD, Naoto Ikeda, MD, Hiroyuki Sugiura, MD, Taiga Kuroi, MD, Shohei Yoshida, MD, Hisakazu Nishimori, MD PhD, Ken-ichi Matsuoka, MD PhD, Nobuharu Fujii, MD PhD, Eisei Kondo, MD PhD, Yoshinobu Maeda, MD PhD, Mitsune Tanimoto, MD PhD

Blood (2016) 128 (22): 3408.

https://doi.org/10.1182/blood.V128.22.3408.3408

Published: 2016

Journal Articles

Successful Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Mild Renal Dysfunction Calculated By Creatinin Clearance

Shuntaro Ikegawa, MD, Tomoko Inomata, MD, Naoto Ikeda, MD, Hiroyuki Sugiura, MD, Taiga Kuroi, MD, Takeru Asano, MD, Shohei Yoshida, MD, Hisakazu Nishimori, MD PhD, Ken-ichi Matsuoka, MD PhD, Nobuharu Fujii, MD PhD, Eisei Kondo, MD PhD, Yoshinobu Maeda, MD PhD, Mitsune Tanimoto, MD PhD

Blood (2016) 128 (22): 4656.

https://doi.org/10.1182/blood.V128.22.4656.4656

Published: 2016

Journal Articles

Clinical Significance of Risk Stratification Based on Disease Risk Index and Hematopoietic Cell Transplantation-Comorbidity Index

Takayuki Sato, MD PhD, Shinichi Ochi, MD, Takashi Nagayama, MD, Shogo Nabe, MD, Kazuya Sakai, MD, Hiroyuki Muranushi, MD, Yusuke Okamoto, MD, Hiroyuki Sugiura, MD, Kazuya Okada, MD, Aki Sato, MD PhD, Takeshi Maeda, MD, Tatsuhito Onishi, MD, Yasunori Ueda, MD PhD

Blood (2014) 124 (21): 2539.

https://doi.org/10.1182/blood.V124.21.2539.2539

Published: 2014

Journal Articles

Absolute Lymphocyte Count As an Independent Prognostic Factor of IPI and NCCN-IPI in DLBCL Patients

Kazuya Okada, MD, Shinichi Ochi, MD, Takashi Nagayama, MD, Shogo Nabe, MD, Kazuya Sakai, MD, Hiroyuki Muranushi, MD, Yusuke Okamoto, MD, Hiroyuki Sugiura, MD, Aki Sato, MD PhD, Takayuki Sato, MD PhD, Takeshi Maeda, MD, Tatsuhito Onishi, MD, Yasunori Ueda, MD PhD

Blood (2014) 124 (21): 1636.

https://doi.org/10.1182/blood.V124.21.1636.1636

Published: 2014

Journal Articles

SUV Max Reduction Criteria of Interim Positron Emission Tomography Improves Prognostic Value in Diffuse Large B-Cell Lymphoma: A Single-Center Retrospective Review

Yusuke Okamoto, MD, Shinichi Ochi, MD, Takashi Nagayama, MD, Shogo Nabe, MD, Kazuya Sakai, MD, Hiroyuki Muranushi, MD, Hiroyuki Sugiura, MD, Kazuya Okada, MD, Aki Sato, MD PhD, Takayuki Sato, MD PhD, Takeshi Maeda, MD, Tatsuhito Onishi, MD, Yasunori Ueda, MD PhD

Blood (2014) 124 (21): 1654.

https://doi.org/10.1182/blood.V124.21.1654.1654

Published: 2014

Journal Articles

Pre-Treatment WT1 mRNA Expression Level In Peripheral Blood Predicts Response and Overall Survival Of Myelodysplastic Syndrome Patients In The Azacitidine Era

Tomoyasu Jo, MD, Kazuya Sakai, MD, Hiroyuki Muranushi, MD, Yusuke Okamoto, MD, Taku Tsukamoto, MD, Hiroyuki Sugiura, MD, Hiroyuki Matsui, MD, Tomoaki Ueda, MD, Kazuya Okada, MD, Takeshi Maeda, MD, Tatsuhito Onishi, MD, Akane Kunitomi, MD, PhD, Yasunori Ueda, MD, PhD

Blood (2013) 122 (21): 1528.

https://doi.org/10.1182/blood.V122.21.1528.1528

Published: 2013

Journal Articles

The Curative Potential Of Fludarabine125, Melphalan100, and Busulfan4 As a Conditioning Regimen For Myeloid Malignancies Of Elderly Patients

Tomoaki Ueda, MD, Aki Sato, M.D., Kazuya Sakai, MD, Hiroyuki Muranushi, MD, Yusuke Okamoto, MD, Taku Tsukamoto, MD, Hiroyuki Sugiura, MD, Hiroyuki Matsui, MD, Tomoyasu Jo, MD, Kazuya Okada, MD, Takeshi Maeda, MD, Tatsuhito Onishi, MD, Akane Kunitomi, MD, PhD, Yasunori Ueda, MD, PhD

Blood (2013) 122 (21): 4551.

https://doi.org/10.1182/blood.V122.21.4551.4551

Published: 2013

Journal Articles

Risk Factors and Prognosis of Hemorrhagic Cystitis after Allogeneic Stem Cell Transplantation: Retrospective Analysis in a Single Institution

Yasuyuki Arai, MD, Takeshi Maeda, MD, Hiroyuki Sugiura, MD, Hiroyuki Matsui, MD, Tomoko Moriwake, MD, Tomoyasu Jo, MD, Tomoaki Ueda, MD, Kazuya Okada, MD, Takahito Kawata, MD, Tatsuhito Oonishi, MD, Chisato Mizutani, MD, Fumio Matsuyama, MD, Yasunori Ueda, MD

Blood (2010) 116 (21): 2304.

https://doi.org/10.1182/blood.V116.21.2304.2304

Published: 2010

NARROW

Posttransplant Cyclophosphamide Promote Naïve-Subset Dominant B Cell Recovery Coordinated with Early Treg Expansion; Implication of Reduced Risk of Pathogenesis into Chronic Gvhd

Mechanistic Analysis of Prolonged Negative Impacts of Anti-CCR4 Antibody Mogamulizumab on Regulatory T Cell Homeostasis after Allogeneic Hematopoietic Stem Cell Transplantation

Post-Transplant Cyclophosphamide Ameliorates Lethal Thymic GVHD By Restoring Regulatory and Effector T Cell Homeostasis in Recipients with Prior PD-1 Blockade Therapy

Early Administration of Low-Dose IL-2 Intensify Graft-Versus-Leukemia Effect without Worsening GVHD through Sequential Enhancement of Effector T Cell and CD62L+ Regulatory T Cell Subset

Liposomal Alpha-Galactosylceramide Ameliorates Graft-Versus-Host Disease with Remaining Intensified GVL Gained By Dose-Reduction of Posttransplant Cyclophosphamaide after Haploidentical HSCT

Essential Role of Regulatory T Cells on Early B Cell Reconstitution after Haploidentical BMT with Posttransplant Cyclophosphamide

Loss of the GVL Effect By Distinct Expression of Migration Markers As a Mechanism of Immune Escape in Adult T Cell Leukemia/Lymphoma (ATLL), a Malignant Counterpart of Regulatory T Cells

Impact of Incomplete Blood Count Recovery Prior to Allogeneic Hematopoietic Stem Cell Transplantation on Engraftment and Early Infection in Patients with Acute Myeloid Leukemia

Successful Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Mild Renal Dysfunction Calculated By Creatinin Clearance

Clinical Significance of Risk Stratification Based on Disease Risk Index and Hematopoietic Cell Transplantation-Comorbidity Index

Absolute Lymphocyte Count As an Independent Prognostic Factor of IPI and NCCN-IPI in DLBCL Patients

SUV Max Reduction Criteria of Interim Positron Emission Tomography Improves Prognostic Value in Diffuse Large B-Cell Lymphoma: A Single-Center Retrospective Review

Pre-Treatment WT1 mRNA Expression Level In Peripheral Blood Predicts Response and Overall Survival Of Myelodysplastic Syndrome Patients In The Azacitidine Era

The Curative Potential Of Fludarabine125, Melphalan100, and Busulfan4 As a Conditioning Regimen For Myeloid Malignancies Of Elderly Patients

Risk Factors and Prognosis of Hemorrhagic Cystitis after Allogeneic Stem Cell Transplantation: Retrospective Analysis in a Single Institution

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only